Wealth Collab, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Wealth Collab, LLC
- $157 Billion
- Q4 2024
A detailed history of Wealth Collab, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Collab, LLC holds 39 shares of CPRX stock, worth $819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$819
Previous $776,000
4.9%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$393 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$177 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$122 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$65.9 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$63.3 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.16B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...